Karyopharm Therapeutics | KPTI - EPS Earnings Per Share


Karyopharm Therapeutics reported $-2.22 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Abbott USD 1.15 0.35 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
MacroGenics USD -0.58 0.36 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Novartis USD 1.99 0.04 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Takeda JPY -15.56 81.3 Mar/2026
Tectonic Therapeutic USD -1.34 0.32 Mar/2026
TG Therapeutics USD 0.12 0.02 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Xencor USD -1.71 1.62 Mar/2026